LT2462158T - Viruso pašalinimo pagerinimo būdas, atliekant baltymų gryninimą - Google Patents

Viruso pašalinimo pagerinimo būdas, atliekant baltymų gryninimą

Info

Publication number
LT2462158T
LT2462158T LTEP10740823.9T LT10740823T LT2462158T LT 2462158 T LT2462158 T LT 2462158T LT 10740823 T LT10740823 T LT 10740823T LT 2462158 T LT2462158 T LT 2462158T
Authority
LT
Lithuania
Prior art keywords
protein purification
virus removal
improve virus
improve
removal
Prior art date
Application number
LTEP10740823.9T
Other languages
English (en)
Inventor
Amit Mehta
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42985499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2462158(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of LT2462158T publication Critical patent/LT2462158T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
LTEP10740823.9T 2009-08-06 2010-08-06 Viruso pašalinimo pagerinimo būdas, atliekant baltymų gryninimą LT2462158T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23181109P 2009-08-06 2009-08-06
PCT/US2010/044760 WO2011031397A1 (en) 2009-08-06 2010-08-06 Method to improve virus removal in protein purification

Publications (1)

Publication Number Publication Date
LT2462158T true LT2462158T (lt) 2018-03-26

Family

ID=42985499

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP10740823.9T LT2462158T (lt) 2009-08-06 2010-08-06 Viruso pašalinimo pagerinimo būdas, atliekant baltymų gryninimą

Country Status (25)

Country Link
US (4) US10662237B2 (lt)
EP (2) EP3309168A1 (lt)
JP (5) JP2013501075A (lt)
KR (3) KR20180035936A (lt)
CN (2) CN102712691A (lt)
AU (1) AU2010292897B2 (lt)
BR (1) BR112012002574A2 (lt)
CA (1) CA2770235C (lt)
DK (1) DK2462158T3 (lt)
ES (1) ES2662529T3 (lt)
HR (1) HRP20180309T1 (lt)
HU (1) HUE038451T2 (lt)
IL (3) IL217740B (lt)
LT (1) LT2462158T (lt)
MX (1) MX346115B (lt)
MY (1) MY188566A (lt)
NO (1) NO2462158T3 (lt)
NZ (1) NZ597809A (lt)
PL (1) PL2462158T3 (lt)
PT (1) PT2462158T (lt)
RU (1) RU2573894C2 (lt)
SG (1) SG178276A1 (lt)
SI (1) SI2462158T1 (lt)
WO (1) WO2011031397A1 (lt)
ZA (1) ZA201200626B (lt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
JP5856845B2 (ja) 2008-10-20 2016-02-10 アッヴィ・インコーポレイテッド 抗体精製中におけるウイルスの不活性化
CA2932207A1 (en) 2008-10-20 2010-12-09 Abbvie Inc. Isolation and purification of antibodies using protein a affinity chromatography
MX346115B (es) 2009-08-06 2017-03-08 Genentech Inc * Metodo para mejorar la eliminación de virus en la purificacion proteica.
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
TR201810703T4 (tr) * 2011-03-25 2018-08-27 Hoffmann La Roche Yeni protein saflaştırma yöntemleri.
DE102011105525B4 (de) * 2011-06-24 2015-03-26 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Biopolymer-Aggregaten und Viren aus einem Fluid
WO2013028330A2 (en) * 2011-08-19 2013-02-28 Emd Millipore Corporation Methods of reducing level of one of more impurities in a sample during protein purification
TR201815709T4 (tr) 2011-12-22 2018-11-21 Hoffmann La Roche İyon değişim membranı kromatografisi.
NZ756749A (en) 2013-09-13 2022-05-27 Genentech Inc Methods and compositions comprising purified recombinant polypeptides
RU2016107435A (ru) 2013-09-13 2017-10-18 Дженентек, Инк. Композиции и способы обнаружения и количественного определения белка клеток-хозяев в клеточных линиях и рекомбинантные полипептидные продукты
PE20171131A1 (es) * 2014-10-21 2017-08-09 Gennova Biopharmaceuticals Ltd Proceso novedoso de purificacion para el aislamiento y produccion comercial de tnk-tpa recombinante (tenecteplasa)
EP3274359B1 (en) * 2015-03-23 2022-11-02 Alexion Pharmaceuticals, Inc. Virus filtration
WO2018230397A1 (ja) * 2017-06-12 2018-12-20 旭化成メディカル株式会社 タンパク質含有液のろ過方法
HUE057850T2 (hu) * 2017-12-21 2022-06-28 Genzyme Corp Eljárások szennyezõdések fokozott eltávolítására A fehérje kromatográfia során

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
WO1981001145A1 (en) 1979-10-18 1981-04-30 Univ Illinois Hydrolytic enzyme-activatible pro-drugs
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
GB8705477D0 (en) 1987-03-09 1987-04-15 Carlton Med Prod Drug delivery systems
US4975278A (en) 1988-02-26 1990-12-04 Bristol-Myers Company Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
CA1338518C (en) 1987-09-23 1996-08-13 Joyce M. Zarling Antibody heteroconjugates for the killing of hiv-infected cells
ATE105585T1 (de) 1987-12-21 1994-05-15 Univ Toledo Transformation von keimenden pflanzensamen mit hilfe von agrobacterium.
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
JPH02198687A (ja) 1989-01-26 1990-08-07 Asahi Chem Ind Co Ltd 純水の製造方法
JPH038759A (ja) 1989-03-16 1991-01-16 Sumitomo Metal Ind Ltd 半導体磁器物質
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
DE69029036T2 (de) 1989-06-29 1997-05-22 Medarex Inc Bispezifische reagenzien für die aids-therapie
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
EP0586505A1 (en) 1991-05-14 1994-03-16 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
ES2206447T3 (es) 1991-06-14 2004-05-16 Genentech, Inc. Anticuerpo humanizado para heregulina.
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
JPH07501451A (ja) 1991-11-25 1995-02-16 エンゾン・インコーポレイテッド 多価抗原結合タンパク質
ATE149570T1 (de) 1992-08-17 1997-03-15 Genentech Inc Bispezifische immunoadhesine
CN1130353A (zh) * 1993-07-09 1996-09-04 史密丝克莱恩比彻姆公司 蛋白质的纯化
CA2106612C (en) 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
HU218159B (hu) * 1993-09-21 2000-06-28 Hemosol Inc. Kiszorításos kromatográfiás eljárás tisztított hemoglobintermék előállítására
JP3415222B2 (ja) 1993-10-20 2003-06-09 東洋濾紙株式会社 エンドトキシン吸着能を有するポリエーテルサルホン又はスルホン化ポリエーテルサルホン微孔膜
JP3453623B2 (ja) 1994-03-30 2003-10-06 サンスター株式会社 エンドトキシン吸着除去剤および除去方法
EP0772488B1 (en) 1994-07-28 2001-01-31 Millipore Corporation Porous composite membrane and process
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
ATE238321T1 (de) 1996-02-06 2003-05-15 Roche Diagnostics Gmbh Verfahren zur herstellung von gereinigter nukleinsäure und deren verwendung
TW505655B (en) 1997-10-14 2002-10-11 Tanox Inc Enhanced aggregate removal from bulk-biologicals using ion exchange chromatography
GB9907553D0 (en) 1999-04-01 1999-05-26 Cantab Pharma Res Purification of biological preparations
AU778022B2 (en) 1999-07-30 2004-11-11 Genentech Inc. Charged filtration membranes and uses therefor
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
US6806355B2 (en) 2001-08-14 2004-10-19 Statens Serum Institut Purification process for large scale production of Gc-globulin, the Gc-globulin produced hereby, a use of Gc.globulin and a Gc-globulin medicinal product
US7118675B2 (en) * 2002-02-04 2006-10-10 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
CA2478925C (en) 2002-04-26 2016-06-07 Robert Lee Fahrner Non-affinity purification of proteins
US7220356B2 (en) 2002-09-13 2007-05-22 Biogen Idec Inc. Method of purifying polypeptides by simulated moving bed chromatography
EP1403274A1 (en) 2002-09-30 2004-03-31 Meristem Therapeutics Process for the purification of recombinant proteins from complex media and purified proteins obtained thereby
US20040116676A1 (en) 2002-09-30 2004-06-17 Hotta Joann Methods for removal of contaminants from blood product solutions
GB0304576D0 (en) 2003-02-28 2003-04-02 Lonza Biologics Plc Protein a chromatography
JPWO2004087761A1 (ja) 2003-03-31 2006-07-27 麒麟麦酒株式会社 ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
KR101224235B1 (ko) 2003-04-11 2013-01-25 메디뮨 엘엘씨 재조합 ｉｌ­９ 항체 및 그의 용도
CA2546054C (en) * 2003-12-10 2014-05-13 Medarex, Inc. Interferon alpha antibodies and their uses
ES2687671T3 (es) 2004-01-30 2018-10-26 Shire Pharmaceuticals Ireland Limited Arilsulfatasa A recombinante para reducir los niveles de galatosil sulfátidos en un sujeto
KR20070009995A (ko) 2004-01-30 2007-01-19 수오멘 푸나이넨 리스티 베리팔베루 바이러스 안전성 면역글로불린을 제조하는 방법
US7390403B2 (en) 2004-03-19 2008-06-24 Millipore Corporation Prefilter system for biological systems
WO2006042541A1 (en) 2004-10-21 2006-04-27 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method
JP2006249082A (ja) * 2005-03-08 2006-09-21 Pharmacia & Upjohn Co Llc 低減レベルの内毒素を有する抗ｍ−ｃｓｆ抗体組成物
WO2007108955A1 (en) * 2006-03-20 2007-09-27 Medarex, Inc. Protein purification
EP1854810A1 (en) 2006-05-09 2007-11-14 PanGenetics B.V. Deimmunized antagonistic anti-human CD40 monoclonal antibody from the ch5D12 antibody
WO2009017491A1 (en) * 2006-06-14 2009-02-05 Smithkline Beecham Corporation Methods for purifying antibodies using ceramic hydroxyapatite
WO2008025747A1 (en) 2006-08-28 2008-03-06 Ares Trading S.A. Process for the purification of fc-fusion proteins
US20080132688A1 (en) 2006-09-22 2008-06-05 Amgen Inc. Methods for Removing Viral Contaminants During Protein Purification
JP5795833B2 (ja) 2006-10-27 2015-10-14 エルパス・インコーポレイテッドＬｐａｔｈ， Ｉｎｃ． スフィンゴシン−１−リン酸と結合させるための組成物および方法
WO2008073620A2 (en) 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
CA2668771C (en) 2006-11-08 2016-03-15 Wyeth Rationally designed media for cell culture
DK2154244T3 (en) 2007-04-26 2017-06-12 Chugai Pharmaceutical Co Ltd CELL CULTIVATION PROCEDURE WHEN AN ACID-ENRICHED MEDIUM IS USED
CA2708951A1 (en) 2007-12-21 2009-07-09 Genetech, Inc. Crystallization of anti-cd20 antibodies
US20110105725A1 (en) 2008-05-15 2011-05-05 Novo Nordisk A/S Antibody purification process
JP5755136B2 (ja) * 2009-03-27 2015-07-29 旭化成メディカル株式会社 高濃度モノクローナル抗体溶液中のウイルス除去方法
TWI445714B (zh) 2009-05-27 2014-07-21 Baxter Int 產製用於皮下使用之高濃度免疫球蛋白製備物之方法
MX346115B (es) 2009-08-06 2017-03-08 Genentech Inc * Metodo para mejorar la eliminación de virus en la purificacion proteica.
US9428548B2 (en) 2009-09-01 2016-08-30 Genentech, Inc. Enhanced protein purification through a modified protein A elution

Also Published As

Publication number Publication date
MX2012001659A (es) 2012-04-30
KR20130051431A (ko) 2013-05-20
SG178276A1 (en) 2012-03-29
JP2016106096A (ja) 2016-06-16
EP2462158A1 (en) 2012-06-13
AU2010292897B2 (en) 2016-01-07
EP3309168A1 (en) 2018-04-18
AU2010292897A1 (en) 2012-02-16
JP2013501075A (ja) 2013-01-10
ZA201200626B (en) 2013-06-26
RU2573894C2 (ru) 2016-01-27
JP2023029853A (ja) 2023-03-07
IL217740A0 (en) 2012-03-29
KR20180035936A (ko) 2018-04-06
HRP20180309T1 (hr) 2018-03-23
EP2462158B1 (en) 2018-01-10
CN102712691A (zh) 2012-10-03
MX346115B (es) 2017-03-08
JP2017206529A (ja) 2017-11-24
US20220306726A1 (en) 2022-09-29
CN106905413A (zh) 2017-06-30
BR112012002574A2 (pt) 2020-11-03
KR20190018041A (ko) 2019-02-20
JP2020023491A (ja) 2020-02-13
CA2770235C (en) 2021-06-29
US20200347118A1 (en) 2020-11-05
HUE038451T2 (hu) 2018-10-29
SI2462158T1 (en) 2018-04-30
ES2662529T3 (es) 2018-04-06
US20110034674A1 (en) 2011-02-10
WO2011031397A1 (en) 2011-03-17
KR101844859B1 (ko) 2018-05-18
IL217740B (en) 2020-04-30
NO2462158T3 (lt) 2018-06-09
PL2462158T3 (pl) 2018-05-30
IL273486A (en) 2020-05-31
US20240083980A1 (en) 2024-03-14
DK2462158T3 (en) 2018-03-05
IL273486B (en) 2022-04-01
US11225513B2 (en) 2022-01-18
US10662237B2 (en) 2020-05-26
PT2462158T (pt) 2018-02-23
NZ597809A (en) 2014-05-30
CA2770235A1 (en) 2011-03-17
RU2012108318A (ru) 2013-09-20
MY188566A (en) 2021-12-22
IL287431A (en) 2021-12-01

Similar Documents

Publication Publication Date Title
IL287431A (en) A method to improve the removal of viruses in the purification of proteins
HRP20181357T1 (hr) Novi postupci pročišćavanja proteina
EP2501666A4 (en) PROCESS FOR PURIFYING AND STABILIZING CHLOROOLEFINS
IL232558A0 (en) Protein purification by Bis-Tris buffer
EP2694660A4 (en) EFFICIENT IN VIVO PROTEIN EXPRESSION USING MODIFIED RNA (MOD RNA)
IL215082A0 (en) Methods of purifying small modular immunopharmaceutical proteins
ZA201300606B (en) Process for removing,isolating and purifying dicarboxylic acids
IL243248A0 (en) Purification method
EP2395211A4 (en) EXHAUST PURIFICATION APPARATUS
GB201012603D0 (en) Protein purification
PL2598516T3 (pl) Proces oczyszczania białek
EP2655651A4 (en) A cost-effective method for expressing and purifying recombinant proteins in plants
EP2711421A4 (en) METHOD OF SEPARATING AND PURIFYING RNA FROM BIOLOGICAL MATERIAL
PL2662338T3 (pl) Układ do oczyszczania zanieczyszczonej wody i sposób oczyszczania
EP2519537A4 (en) CLEANING PROTEINS
ZA201105048B (en) Process for purifying guar
EP2702065A4 (en) DNA EXTRACTION IN TARGET MOLECULE PURIFICATION
IL229383A0 (en) A process for purifying protein with a low acidity level
IL218260A0 (en) Method for purifying gla-domain coagulation proteins
EP2603234A4 (en) PROCESS FOR REDUCING DNA UNREINTH IN VIRAL COMPOSITIONS
ZA201301381B (en) Water purification process and system
GB0815538D0 (en) Improvements to purification method and apparatus
GB0904792D0 (en) Improvements in or relating to waste treatment